CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?Zacks Investment Research • 04/14/23
CRISPR Therapeutics to Participate in Needham's 22nd Annual Healthcare ConferenceGlobeNewsWire • 04/13/23
Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a BetZacks Investment Research • 04/12/23
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase GlobalBenzinga • 04/06/23
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta ThalassemiaBusiness Wire • 04/03/23
Is CRISPR Therapeutics (CRSP) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 03/29/23
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex's Hypoimmune Cell Therapies for the Treatment of Type 1 DiabetesBusiness Wire • 03/27/23